Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | -0.00 |
| price to book ratio | 0.00 |
| price to sales ratio | 0.03 |
| enterprise value multiple | -0.73 |
| price fair value | 0.00 |
profitability ratios | |
|---|---|
| gross profit margin | -5249.4% |
| operating profit margin | -9630.12% |
| pretax profit margin | -8508.43% |
| net profit margin | -8215.66% |
| return on assets | -48.82% |
| return on equity | -101.74% |
| return on capital employed | -76.22% |
liquidity ratio | |
|---|---|
| current ratio | 2.16 |
| quick ratio | 2.16 |
| cash ratio | 1.45 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 8,452.17 |
| days of payables outstanding | 138.85 |
| cash conversion cycle | 8,313.32 |
| receivables turnover | 0.04 |
| payables turnover | 2.63 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.03 |
| debt equity ratio | 0.04 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.04 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -20.29 |
cash flow ratios | |
|---|---|
| free cash flow per share | -23.70 |
| cash per share | 15.41 |
| operating cash flow per share | -23.63 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -20.29 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -352.36 |
Frequently Asked Questions
When was the last time Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) reported earnings?
Biodexa Pharmaceuticals Plc (BDRX) published its most recent earnings results on 30-06-2024.
What is Biodexa Pharmaceuticals Plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Biodexa Pharmaceuticals Plc (NASDAQ:BDRX)'s trailing twelve months ROE is -101.74%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Biodexa Pharmaceuticals Plc (BDRX) currently has a ROA of -48.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BDRX's net profit margin stand at?
BDRX reported a profit margin of -8215.66% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BDRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.16 in the most recent quarter. The quick ratio stood at 2.16, with a Debt/Eq ratio of 0.04.